Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fisetin in at-risk COVID-19 outpatients
NCT04771611Phase 2Completed
- Start
- Jul 2021
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fisetin in coronavirus disease 2019 (COVID-19). Started Jul 2021; status: completed.
02
Drugs
fisetin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04771611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04771611.